Nephrectomy is considered the backbone of managing patients with localized and selected metastatic renal cell carcinoma (mRCC). The prognostic role of nephrectomy has been widely investigated with cytokines and targeted therapy, but it is still unclear in the immunotherapy era.

The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study

Boccardo, Francesco;Morelli, Franco;
2022-01-01

Abstract

Nephrectomy is considered the backbone of managing patients with localized and selected metastatic renal cell carcinoma (mRCC). The prognostic role of nephrectomy has been widely investigated with cytokines and targeted therapy, but it is still unclear in the immunotherapy era.
2022
Bone metastases
IMDC score
Immunotherapy
Meet URO score
Metastatic renal cell carcinoma
Nephrectomy
Neutrophil to lymphocyte ratio
Nivolumab
Prognostic
Cytokines
Humans
Immunotherapy
Nephrectomy
Nivolumab
Prognosis
Retrospective Studies
Carcinoma, Renal Cell
Kidney Neoplasms
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/588294
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 5
  • ???jsp.display-item.citation.isi??? ND
social impact